KIM HOANG: Open Payments
NPI 1467123604 · STANFORD, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$343 in 6 payments from 4 companies in 2025. Trend: 2023 $194 · 2024 $77 · 2025 $343
Food & beverage: $343
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 1 | $125 |
| Aimmune Therapeutics, Inc. | 1 | $119 |
| UCB, Inc. | 2 | $58 |
| IBSA Pharma Inc. | 2 | $41 |
Products named: Wegovy, ZENPEP, Bimzelx, Tirosint.
Industry payments across CA — which companies pay providers there.
